Upload
miranda-davidson
View
215
Download
2
Embed Size (px)
Citation preview
Chronic Pelvic Pain
There is no generally accepted definition of chronic pelvic pain
Many authors have used duration of at least 6 months that occurs below the umbilicus and is severe enough to cause functional disability or require treatment (some prefer non-cyclic)
Chronic Pelvic Pain
Approx 15-20% of women ages 18-50 yrs have chronic pelvic pain greater than 1 yrs duration
20% of all hysterectomies performed for benign disease
40 % of all gynecological laparoscopies performed annually in the United States
Population at Increased Risk
Demographic profiles of large surveys suggest that women with chronic pelvic pain are no different in terms of age, race and ethnicity, education, socioeconomic status, or employment status
May be slightly more likely to be separated or divorced
Tend to be of reproductive age Age is not a specific risk factor
Physical and Sexual Abuse
Significant association of physical and sexual abuse with various chronic pain disorders 40-50% have a history of abuse May decrease threshold for pain Important to ensure they are not currently being
abused or in danger
Gynecologic Causes of Pelvic Pain
EndometriosisAdhesions (chronic PID)LeiomyomataAdenomyosisPelvic congestion syndromeMittelschmerzAdnexal masses
Etiology
Study from UK Urinary Causes – 30.8% GI Causes- 37.7% Gynecologic- 20.2%
Many women with chronic pelvic pain have more than 1 disease that may lead to pain 25-50% women who received medical care in primary care
practices have more than 1 diagnosis along with chronic pelvic pain IBS, endometriosis, IC
Women with more than 1 organ system diagnosis have greater pain
History
Characteristics of the pain:
Location and radiation
Intensity, including intensity with menstrual cycle, urination, defecation, and physical activity, if relevant
Timing, especially if only at menses or with intercourse
Quality
Lab Tests
Laboratory Laboratory testing is of limited value in evaluating women
with CPP Baseline tests are obtained to screen for a chronic
infectious or inflammatory process, and to exclude pregnancy CBC with diff UA G/C Pregnancy test Further laboratory testing is based on the clinical
impression that emerges after a complete history and physical examination
Imaging
Pelvic US Highly sensitive for identifying pelvic masses/cysts and
determining the origin of the mass (ovary, uterus, fallopian tube)
Less reliable for distinguishing between benign and malignant neoplasms and diagnosing adenomyosis
Particularly useful for detecting small pelvic masses (less than 4 cm in diameter), which often cannot be palpated on bimanual examination
Useful for detecting hydrosalpinges, which point to pelvic inflammatory disease as the cause of CPP
MRI Used to better define an abnormality suspected by
sonography and for diagnosis of adenomyosis
Gastrointestinal Causes of Pelvic Pain
Irritable bowel syndromeChronic appendicitisInflammatory bowel disease (Crohn’s)DiverticulitisDiverticulosisMeckel’s diverticulum
Urologic Causes of Pelvic Pain
Unstable bladder (detrusor instability)Urethral syndrome (chronic urethritis)Interstitial cystitis
Musculoskeletal/Myofascial Causes of Pelvic Pain
FibromyalgiaHernias (inquinal, femoral, umbilical,
incisional, spigelian)Nerve entrapment (neuritis)FasciitisScoliosisDisc diseaseSpondylolisthesisOsteitis pubis
“Top of the list” Etiologies
Gynecologic PID Endometriosis Prior surgery? Pelvic Adhesions
Non-gynecologic IC IBS Musculoskeletal Disorders Psychiatric
PID
18-35% of acute PID develop chronic pelvic pain Actual mechanism not well known Inpatient or outpatient treatment does not reduce the
odds of developing subsequent chronic pelvic pain
Endometriosis
Diagnosed laparoscopically in approx 33% of women with chronic pelvic pain 24% adhesive disease 35% no visible pathology
More than 50% with abnormal laparoscopic findings have normal pre-op exam
Endometriosis
Treatment Medical management
GnRH agonists – Lupron most commonly used May be used for a “suggestive “diagnosis or treatment 6-12 months with add-back norethindrone 5mg for
bone protection and symptom relief Continuous OCPs or higher dose progestins Depo Provera
Surgical Management Hysterectomy Laparoscopy with ablation for mild to mod disease
Treatment
Surgical excision or destruction of endometriotic tissue Significant pain relief for 1 yr in 45-85% of women Recurrence range from 15-100% Avg time to recurrence is 40-50 months Most effective in early disease (not stage IV endometriosis)
Hysterectomy (not just dx of endometriosis) Several prospective cohort studies 90% of women had relief of pain at 1 and 2 yrs post
hysterectomy 1 yr after hysterectomy for chronic pelvic pain, 74% had
complete resolution of pain and 21% had decreased pain Retrospective study of hysterectomy with no path found that
78% were pain free after 1 yr
Past Surgery
History of abdominopelvic surgery associated with chronic pelvic pain
Women without preoperative pain 3-9% develop pelvic pain or back pain in the 2 yrs
after a hysterectomy
Cesarean delivery also may be a risk factor for chronic pelvic pain (OR of 3.7)
Interstitial Cystitis
Clinically characterized by irritative voiding symptoms of urgency and frequency in the absence of objective evidence of other disease
70% of women with IC report pelvic pain
Suggested that 38-85% of women presenting to the gynecologist with chronic pelvic pain may have IC
Difficult to diagnose- no true gold standard Intravesical K instillition of 40ml of KCL Cystoscopy with Hunners ulcers (petechiae or glomerulations) Decreased bladder capacity (less than 350cc) without
anesthesia
Interstitial Cystitis - Treatment
HydrodistentionDimethyl sulfoxide (DMSO) 50%
50cc periodicallyBladder retrainingBiofeedbackAntidepressant (e.g., Elavil, Tofranil)AntihistaminesSSRIsPentosan polysulfate (Elmiron)
IBS
Characterized by chronic, relapsing pattern of abdominopelvic pain and bowel dysfunction with constipation or diarrhea
Symptoms consistent with 50-80% of women with chronic pelvic pain
Current diagnosis is the Rome II Criteria At least 12 wks (not consecutive) in the preceding 12
mo with 2 of 3 features 1. Relieved by defecation 2. Onset associated with change in frequency of stool 3. Onset associated with a change in stool form or
appearance
Medical Treatment of IBSSymptomSymptom TherapyTherapy Typical daily dosageTypical daily dosage Side effectsSide effects
DiarrheaDiarrhea LoperamideLoperamide 4 mg4 mg ConstipationConstipation
DiphenoxylateDiphenoxylate 20 mg20 mg Euphoria, sedationEuphoria, sedation
HyoscyamineHyoscyamine < 1.5 mg< 1.5 mg Dry mouthDry mouth
DicyclomineDicyclomine 80-160 mg80-160 mg Blurred visionBlurred vision
DesipramineDesipramine 150 Mg150 Mg Dry mouth, confusion, Dry mouth, confusion, hypertensionhypertension
AmitriptylineAmitriptyline 25-50 mg25-50 mg Dry mouth, confusionDry mouth, confusion
ConstipationConstipation Fiber (any source)Fiber (any source) >30 g>30 g Bloating, abdominal painBloating, abdominal pain
LactuloseLactulose 10-30 g10-30 g BloatingBloating
SorbitolSorbitol 10-30 mg10-30 mg BloatingBloating
CisaprideCisapride 40-80 mg40-80 mg Dizziness, headacheDizziness, headache
Abdominal painAbdominal pain DesipramineDesipramine 150 mg150 mg Dry mouth, sedation, Dry mouth, sedation, confusion, hypertensionconfusion, hypertension
Hyoscyamine sulfateHyoscyamine sulfate <1.5 mg<1.5 mg Hypotension, constipationHypotension, constipation
DicyclomineDicyclomine 80-160 mg80-160 mg Dry mouth, blurred vision, Dry mouth, blurred vision, dizzinessdizziness
Musculoskeletal Disorders
Trigger pointsFibromyalgiaMyofacial painLumbar vertebral disordersPelvic floor myalgiaFaulty posture
Exaggerated lumbar lordosis and thoracic kyphosis May contribute to up to 75% of chronic pelvic pain
Musculoskeletal Screening Examination for Patients Presenting with Chronic Pelvic Pain -
History
Normal laparoscopyHistory of trauma to low back or
lower extremities, including motor vehicle accident or fall
Pain is altered by positional changes, particularly prolonged standing or sitting
Lack or response to previous gynecologic intervention
Exacerbation with stress
Muscle Relaxants for Patients Presenting with Chronic Pelvic
Pain
Trade nameTrade name Generic nameGeneric name DosageDosage
Parafon ForteParafon Forte ChlorzoxazoneChlorzoxazone 500 mg q tid or qid500 mg q tid or qid
RobaxinRobaxin MethocarbamolMethocarbamol 500 mg 3 tabs qid500 mg 3 tabs qid
Soma compoundSoma compound CarisoprodolCarisoprodol 200 mg 1-2 tabs qid200 mg 1-2 tabs qid
AspirinAspirin 325 mg qid325 mg qid
ValiumValium DiazepamDiazepam 2-10 mg qid2-10 mg qid
Laparoscopy
When do you do one? Suspicious of pathology based on imaging or PE Failed medical management
When endometriosis is suspected on visual findings- biopsies and histological confirmation is important
Adolescents should not be excluded from the rest of the population for laparoscopic evaluation
Treatment
Antidepressants TCAs- imipramine, amitryptyline, desipramine, and
doxepin, have been shown in placebo controlled studies to improve pain levels and pain tolerance in those with chronic pain syndromes Not clear if others such as SSRIs are as effective
“Evidence is insufficient to substantiate efficacy of antidepressants although the efficacy of TCAs for other chronic pain syndromes suggest they also might be efficacious for chronic pelvic pain”
Response Following Administration of Three Major
Antidepressants
# of trials# of trials (in 116 pts)(in 116 pts) TotalTotal
AntidepressantAntidepressant No ReliefNo Relief ReliefRelief TrialTrial
Imipramine Imipramine (Tofranil)(Tofranil)
11 (25%)11 (25%) 33 (75%)33 (75%) 4444
Amitriptyline Amitriptyline (Elavil)(Elavil)
4 (16%)4 (16%) 21 (84%)21 (84%) 2525
Desipramine Desipramine (Norpamin)(Norpamin)
10 (23%)10 (23%) 34 (77%)34 (77%) 4444
TotalTotal 30 (22%)30 (22%) 105 (78%)105 (78%) 135135
Be wary of claims for:
Presacral neurectomyUterine suspensionLUNA (lap US nerve ablation)Surgery for pelvic congestionLysis of adhesionsHysterectomy
Treatment
Analgesics NSAIDS including COX-2 inhibitors relieve various
pain No clinical trials have addressed chronic pelvic pain Opioids are increasingly used but randomized trials
suggest no improvement in functional or psychological status with increased risk in addiction
Treatment
Combined OCPs Provide significant relief
Suppress ovulation Reduce spontaneous uterine activity Stabilize estrogen and progesterone levels Abrogate menstrual increases in prostaglandin levels Reduce the amt of pain and symptoms associated with menses
Recommended for endometriosis-associated chronic pelvic pain One study showed OCPs comparable to GnRH agonist goserelin
in relieving chronic pelvic pain and dysparenia but less effective in relieving dysmenorrhea in women with endometriosis
OCPs do not significantly affect long-term recurrence of endometriosis
Continuous OCPs may be superior- no good data
Treatment
GnRH Agonists “down-regulate” Hypothalamic-pituitary gland production and
release of LH and FSH to reduce estradiol levels significantly Nafarenlin, Goserelin, Leuprolide Emperic treatment with GnRH agonists have the same
efficacy in women with symptoms consistent with endometriosis, whether or not they actually have endometriosis
Strongly suggests the response does not depend on surgical confirmation
Other pain from IBS, IC also vary with the menstrual cycle and respond to GnRH agonist treatment
Good evidence supports add-back therapy with estrogen, progesterone, or both can decrease side effects without loss of efficacy
Treatment
ProgestinsMPA
30-100mg po per day effectively decreases pain from endometriosis and pelvic congestion syndromes
Depo Provera may also be effective but no good studies
Treatment
Exercise Most studies suggest dysmenorrhea is decreased by
exercise but not definitive data on chronic pelvic pain
PT Electrotherapy, fast and slow twitch exercises of the
striated muscles of the pelvic floor, manual therapy of myofascial trigger points shown improvement of pain in 65-70% of patients
Treatment
Psychotherapy Many suggest various modes of psychotherapy
including cognitive therapy, operant conditioning, and behavioral modification appear to be helpful
Up to 50% of women with chronic pelvic pain have a history of physical or sexual abuse
Treatment
Herbal and Nutritional Therapies Many clinical trials of mag, B6, B1, omega 3s, Japanese herbal
combinations have been studies with no conclusive data
Magnestic Field Therapy Application of magnets to trigger paints may improve
symptoms Only one clinical trial has evaluated their use and had
significant methodologic flaws
Acupuncture Acupuncture, acupressure, and transcutaneous nerve
stimulation therapies have shown better than placebo in the treatment of dysmenorrhea
Only case reports for nonmenstrual chronic pelvic pain
Key Points
MULTIPLE ETIOLOGIES!!!!! Detailed history of PE are the basis of differential diagnosis Treatment is more of an art than a science
NSAIDs should be considered for mod pain and dysmenorrhea
Combined OCs primary dysmenorrhea Continuous OCs for long term ovarian suppression
GnRH effective for multiple etiologies of pain Empiric treatment without laparoscopy should be considered
High dose Progestins effective for chronic pelvic pain
Key Points
Laparoscopic surgical destruction of endometriosis best for stage I-III disease
Adding Psychotherapy to medical treatment often improves response
PT appears to be helpful in treatment and should be considered
Hysterectomy relieves 75-95% chronic pelvic pain
Antidepressants may be helpful (TCAs) in treatment of chronic pelvic pain
“If the only tool you have is a hammer, you tend to see every problem as a
nail.”
--Abraham MaslowAbraham Maslow